CLLU1 mainly acts as a stable and inherent diagnostic biomarker of chronic lymphocytic leukemia and is significantly associated with poor clinical outcomes (Buhl et al., 2009; Gonzalez et al., 2013). Here, CLLU1 is linked to B-cell chronic lymphocytic leukemia.